Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia

NCT06955858 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Mobilization

Interventions

DRUG: Recombinant Human Thrombopoietin（rhTPO）

Sponsor

Institute of Hematology & Blood Diseases Hospital, China